Embolization to treat chronic subdural hematoma
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests a minimally invasive procedure called middle meningeal artery embolization (using tiny particles to block a small artery) to treat chronic subdural hematoma, a condition where blood slowly builds up on the brain's surface. The goal is to help the body reabsorb the blood and prevent the need for repeated surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a chronic subdural hematoma (a slow blood collection pressing on the brain) seen on a CT or MRI scan, on one side or both.
- Your doctor thinks you are healthy enough for standard surgery (like a small hole in the skull) to treat it. This study is for people who could have surgery but might also benefit from a less invasive option.
- It can be your first time having this condition, or if it keeps coming back after treatment.
- The hematoma must not be an acute (sudden) bleed or a sudden worsening of a chronic one. Also, it must not be caused by a brain tumor or infection.
- You must be able to safely have angiography (a scan that looks at your blood vessels) and the embolization procedure itself, so no severe dye allergies, bleeding problems, or severe kidney failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients who get a procedure called middle meningeal artery embolization (a treatment that blocks blood flow to the lining of the brain to help a chronic subdural hematoma heal). The goal is to see how well it works and how patients recover over time.
This study tests a new way to treat chronic subdural hematomas (a type of bleeding on the brain) by using a very thin tube to seal off a small artery inside the head. This may help the blood clot shrink without needing a traditional surgery.
This trial tests a procedure that blocks blood flow to the membrane around the brain to treat a chronic subdural hematoma (a slow buildup of blood pressing on the brain). It may help avoid surgery and reduce symptoms like headaches, confusion, or weakness.
This trial tests a new technique during surgery for chronic subdural haematoma (bleeding between the brain and skull) where doctors use heat or special tools to seal a blood vessel (the middle meningeal artery) to help prevent the bleed from returning. The goal is to see if this addition to standard surgery is safe and feasible.
This trial compares different materials used during a procedure to treat chronic subdural hematoma, a collection of old blood on the brain's surface. The goal is to see which material works best to prevent the blood from coming back.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
Hear when a new Middle Meningeal Artery Embolization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.